THURSDAY - DECEMBER 10, 2009
08.00 Registration
08.15 Welcome on behalf of SSIF
R. Fischer, Germany
08.30 Welcome on behalf of ISFP
J. Donnez, Belgium
Cancer therapy and fertility preservation
Chairmen: J. Donnez, Belgium - R. Gosden, USA
08.45 Opening Lecture: Fertility preservation in children. Effect of radiotherapy on the uterus
H.Wallace, UK
09.25 Effect of cytotoxic therapies on the ovary
D. Meirow, Israel
09.50 Effect of cytotoxic therapies on the testis
H. Tournaye, Belgium
10.15 Evaluation of ovarian function before and after chemotherapy - an approach to determine the cytotoxicity of different chemotherapy regimens?
M. Rosendahl, Denmark
10.40 Coffee Break
Chairmen: J.M. Foidart, Belgium - S. Kim, USA - H.Wallace, UK
11.10 GnRH-agonists, is there evidence for a protective effect?
Y. Englert, Belgium
11.35 Effect of chemotherapy and fertility preservation in women with breast cancer
J. Dor, Israel
12.00 The real risk of conservative surgery in women with pelvic gynaecologic disease
P. Morice, France
12.25 Lunch and Poster Visit Session
Cryopreservation and transplantation of ovarian tissue
From ovarian tissue to isolated follicles and whole ovary preservation
Chairmen: D. Meirow, Israel - I. Demeestere, Belgium - P. Pasquale, USA
14.00 Heterotopic transplantation of cryopreservation of human tissue: a 8 years experience
S. Kim, USA
14.25 Orthotopic transplantation of ovarian cortex: review of the world experience
J. Donnez, Belgium
14.50 Transport of ovarian tissue prior to cryopreservation - Experience from Denmark
C.Y. Andersen, Denmark
15.05 Selected oral communications on cryopreservation and transplantation
16.00 Coffee break
Chairmen: C. Yding Andersen, Denmark - M.M. Dolmans, Belgium
16.30 Risk of transplanting ovarian tissue in breast cancer
A. Pellicer, Spain
16.55 Risk of transplanting ovarian tissue in leukemia
D. Meirow, Israel
17.20 Selected oral communications on cryopreservation and transplantation
19.00 End of the day
FRIDAY - DECEMBER 11, 2009
Whole ovary transplantation or artificial ovary: from animal studies to human
Chairmen: S. Gordts, Belgium - M.M. Dolmans, Belgium - C. Tzeng, Taiwan
08.00 Lessons from experimental ovarian transplantation
B. Salle, France
08.25 The preservation of the whole ovary in humans: where we are
P. Patrizio, USA
08.50 Transplantation of fresh ovarian tissue: cortical graft versus whole ovary?
S.J. Silber, USA
09.15 Selected oral communications on whole ovary transplantation
10.00 Coffee break
Testicular tissue preservation
Chairmen: H. Tournaye, Belgium - S.J. Silber, USA
10.30 Testicular tissue preservation: a review
C.Wyns, Belgium
11.05 Selected oral communications on male fertility preservation
12.30 Lunch
Isolated follicles transplantation or in vitro maturation
Chairmen: A. Borini, Italy - A. Pellicer, Spain - S. Suzuki, Japan
14.00 Folliculogenesis in humans: in vivo and in vitro
J. Smitz, Belgium
14.25 IVM: factors affecting oocyte quality
D. Albertini, USA
14:50 Isolation and grafting of human isolated follicles: why and how? A place for an artificial ovary?
M.M. Dolmans, Belgium
15.15 In vitro maturation of human follicles: a biomaterials approach
T.Woodruff, USA
15.40 Bioengineering the ovary
C. Amorim, Belgium
16.05 Coffee break
Chairmen: P. Barri, Spain - J. Smitz, Belgium - T.Woodruff, USA
16.30 Closing the gap between in vitro growth (IVG) and IVM using fresh and cryopreserved tissue
E. Telfer, UK
16.55 Fresh human ovarian tissue: from primordial to antral follicle in culture
O. Hovatta, Sweden
17.20 Impact of cryopreservation and grafting on folliculogenesis
D. Gook, Australia
17.45 In vitro maturation in cancer patients
S.L. Tan, Canada
Chairmen: S. Kim, USA - J. Donnez, Belgium
18.15 Key note lecture: Potential for stem cell renewal of function in sterile ovaries and testes
R. Gosden, USA
19.00 End of the day
SATURDAY - DECEMBER 12, 2009
Chairmen: C. Amorim, Belgium - H.Wallace, UK
08.00 Selected oral communications on cryopreservation and transplantation
Vitrification versus slow freezing
Chairman: R. Gosden, USA
Co-chairmen and discussants: A. Veiga, Spain - P. Barri, Spain - O. Hovatta, Sweden
Oocytes
09.00 Slow freezing versus vitrification - what is more efficient?
A. Borini, Italy
09.20 Pros and cons
A. Veiga, Spain
09.30 Discussion
09.45 Coffee Break
Embryos
10.15 Slow freezing versus vitrification - what is more efficient?
E. Van Den Abbeel, Belgium
10.35 Pros and cons
P. Barri, Spain
10.45 Discussion
Ovarian tissue
11.00 Slow freezing versus vitrification - what is more efficient?
B. Salle, France
11.20 Pros and cons
O. Hovatta, Sweden
11.30 Discussion
Ethics: final lecture
Chairmen: S. Kim, USA - D. Meirow,Israel - P. Patrizio, USA
11.45 Introduction: J. Donnez, Belgium
The next debate: Future, is there a place for ovarian tissue and oocytes cryopreservation for social reasons?
G. Pennings, Belgium
12.30 Prize for oral presentation and poster - Closing Ceremony
J. Donnez, Belgium and ISFP Board Directors
